All the news Showing 10 of 86 articles from: Disease course and symptomsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows Michael Carter / 16 January 2018 Hepatitis C virus (HCV) treatment using direct-acting antivirals (DAAs) is highly effective and safe in harder-to-treat people with HIV co-infection, Spanish researchers report in AIDS. A sustained virological response (SVR), ... Elevated HBV surface antigen, viral load increases liver cancer risk Healio Hepatology / 06 December 2017 Long-term aspirin use reduces the incidence of digestive cancers by up to 47 percent UEG Week press release / 31 October 2017 Daily aspirin therapy linked to lower liver cancer risk Liz Highleyman / 26 October 2017 People with hepatitis B virus (HBV) who took an aspirin a day – often recommended to help prevent cardiovascular disease – had a lower risk of developing liver cancer, according to a ... Nucleos(t)ide analogue reduces risk for liver cancer in HBV Healio Hepatology / 05 October 2017 US FDA approves nivolumab immunotherapy for liver cancer Liz Highleyman / 27 September 2017 The US Food and Drug Administration (FDA) last week granted accelerated approval for nivolumab (Opdivo), an immunotherapy drug that restores T-cell anti-tumour activity, for people with hepatocellular carcinoma. Nivolumab, an antibody ... Liver Cancer is What Killed Jailed Chinese Dissident Lu Xiaobo Hepmag / 17 July 2017 Cirrhosis linked to 30% of chronic HBV patients at initial presentation Healio Hepatology / 15 May 2017 Statins reduce risk of decompensation for people with HCV- and HBV-related cirrhosis Michael Carter / 18 April 2017 Treatment with statins reduces the risk of decompensated liver disease for people with cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), investigators from Taiwan report in the online edition ... Is better treatment reducing liver cancer among people with hepatitis B? Liz Highleyman / 23 February 2017 The incidence of hepatocellular carcinoma (HCC) appears to be decreasing and mortality improving among people with chronic hepatitis B treated with suppressive antiviral therapy, according to studies presented at the recent 2016 AASLD ... ← Prev1...23456...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Transmission and prevention Diagnosis and monitoring Disease course and symptoms Treatment HIV and HBV HCV and HBV Hepatitis delta Living with HBV Hepatitis C Hepatitis D Hepatitis E NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds